VTRS

Viatris

$12.46

+0.01 (+0.08%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 03.01.2026
$12.44
(-0.16%)
Strong Buy: 0
Buy: 3
Hold: 6
Sell: 0
Strong Sell: 1
Description:
Viatris Inc. (VTRS) is a prominent global healthcare provider headquartered in Canonsburg, Pennsylvania, formed through the strategic merger of Mylan and Pfizer's Upjohn division. The company boasts a robust portfolio encompassing generic, branded, and over-the-counter products, aiming to enhance patient access to high-quality healthcare across more than 165 countries. Viatris is dedicated to addressing diverse health challenges through innovative solutions and a comprehensive distribution network, all while focusing on cost-effectiveness and sustainability within the healthcare system. As it navigates an evolving industry landscape, Viatris remains committed to improving patient outcomes and advancing healthcare accessibility worldwide.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Address:
ROBERT J. COURY GLOBAL CENTER, CANONSBURG, PA, UNITED STATES, 15317
Fiscal year end:
December
Market capitalization:
$14.4 Billion
EBITDA:
$4.04 Billion
PERatio:
0.0
EPS:
-3.13
Dividend per share:
$0.48
Dividend yield:
3.83%
Beta:
0.833

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 5 years:
-4%
How much will you get:
$960
Prices dates:
16-11-2020: $12.97 and 31-12-2025: $12.45